DeHeng Chen, LLC (“DeHeng NY”) has advised Shanghai Hongxiao Science and Technology Co., Ltd
(“Shanghai Hongxiao”), a shareholding company of listed company Shanghai Hongda Mining Co., Ltd.
(“Shanghai Hongda”) on its $300 million acquisition of an 80% equity interest in miVIP Healthcare
Holdings, LLC (“miVIP”), a healthcare management company. The deal closed on January 1, 2018.
As the U.S. counsel to Shanghai Hongda and Shanghai Hongxiao for this acquisition, DeHeng NY advised
on pre-closing legal due diligence, healthcare regulatory compliance, negotiation and drafting of
transactional documents, CFIUS review and HSR filings, and deal closing.
Xiaomin Chen, Managing Partner of DeHeng NY, led a team of lawyers comprising Shang Jiang, Deborah
Yang, Adam Eilenberg, Ted Chastain, James Shorter and other counsel.
